{
  "id": "5890eb22621ea6ff7e000006",
  "type": "yesno",
  "question": "Can Pentraxin 3 predict outcomes of sepsis?",
  "ideal_answer": "Yes, Pentraxin 3 s an objective biochemical marker in diagnosis of sepsis; it is helpful in assessment of severity and prognosis of sepsis; it also has a certain clinical value in the assessment of sepsis cardiovascular function damage.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15977234",
    "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
    "http://www.ncbi.nlm.nih.gov/pubmed/25227610",
    "http://www.ncbi.nlm.nih.gov/pubmed/26982005",
    "http://www.ncbi.nlm.nih.gov/pubmed/27864924",
    "http://www.ncbi.nlm.nih.gov/pubmed/26872435",
    "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
    "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
    "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
    "http://www.ncbi.nlm.nih.gov/pubmed/22278372",
    "http://www.ncbi.nlm.nih.gov/pubmed/26717657",
    "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
    "http://www.ncbi.nlm.nih.gov/pubmed/25530683",
    "http://www.ncbi.nlm.nih.gov/pubmed/25048752",
    "http://www.ncbi.nlm.nih.gov/pubmed/25591437",
    "http://www.ncbi.nlm.nih.gov/pubmed/24039869",
    "http://www.ncbi.nlm.nih.gov/pubmed/21423699"
  ],
  "snippets": [
    {
      "text": "As compared with low serum PTX3and sTWEAK cases, cirrhotic patients with high serum PTX3/sTWEAK levels a have higher probability of new severe infections, severe sepsis, septic shock, type 1 hepatorenal syndrome, in-hospital, and 3-month follow-up mortalities. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872435",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Neonates with high nPTX3 concentrations also have lowered APGAR scores, increased rate of respiratory distress syndrome, clinical sepsis, IVH, necrotizing enterocolitis and prolonged NICU stay.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25048752",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In terms of predicting the prognosis of sepsis with heart failure complications, the PTX3 value's area under ROC curve was larger than that of BNP (respectively 0. 844, 0. 472).CONCLUSION: The PTX3 is an objective biochemical marker in diagnosis of sepsis; it is helpful in assessment of severity and prognosis of sepsis; it also has a certain clinical value in the assessment of sepsis cardiovascular function damage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26717657",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Together, these results suggest that elevation of PTX3 is associated with fulminant disease during A. baumannii sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PTX3, as a mediator of inflammation, may represent an early marker of severity and outcome in sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: Persisting high levels of circulating PTX3 over the first days from sepsis onset may be associated with mortality. PTX3 correlates with severity of sepsis and with sepsis-associated coagulation/fibrinolysis dysfunction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27864924",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26982005",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The prototypic long pentraxin, pentraxin 3, is an acute phase protein that is structurally related but distinct from C-reactive protein which has proven to correlate with the severity of bacterial infection in critically ill patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15977234",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In addition, high levels of PTX3 were associated with unfavorable outcome.CONCLUSIONS: The long pentraxin PTX3 is elevated in critically ill patients and correlates with severity of disease and infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PTX3, as a mediator of inflammation, may represent an early marker of severity and outcome in sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22278372",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018805",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000066891",
    "http://www.biosemantics.org/jochem#4264880"
  ],
  "exact_answer": "Yes"
}